Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Viral Hepat ; 13(6): 402-8, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16842443

ABSTRACT

Indoleamine 2,3-dioxygenase (IDO), a key enzyme of tryptophan (TRP) metabolism, is induced in various tissues of patients with bacterial and viral infection or with neoplastic diseases. This induction is considered the main cause of the decreased serum TRP levels, the reduced brain serotonin synthesis and the occurrence of psychopathological disorders often detected in patients with chronic infections or different forms of cancer. We studied 89 subjects including: (a) 39 patients with chronic hepatitis C virus (HCV) infection and mild liver damage (b) 40 healthy controls, and (c) 10 patients with chronic hepatitis B virus (HBV) infection. We measured serum TRP and kynurenine levels and IDO activity in macrophages. Furthermore, each patient had an accurate psychopathological evaluation. HCV-infected patients had lower (-28%) serum TRP concentrations than healthy volunteers or HBV-infected patients with comparable liver damage. Depression and anxiety symptoms were particularly common in HCV patients. Unexpectedly, serum kynurenine levels and IDO activity in cultured macrophages (under both basal or stimulated conditions) were lower in HCV patients than in controls. Our study shows that HCV patients have reduced serum TRP levels and confirms that they frequently suffer from anxiety and depression-related symptoms. The reduced IDO activity found in the macrophages of these patients suggest that HCV infection may hamper macrophage functions.


Subject(s)
Hepatitis C, Chronic/metabolism , Hepatitis C, Chronic/psychology , Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism , Macrophages/enzymology , Tryptophan/blood , Adult , Anxiety , Depression , Female , Hepacivirus/pathogenicity , Humans , Kynurenine/blood , Male , Middle Aged
2.
Neuropharmacology ; 48(6): 788-95, 2005 May.
Article in English | MEDLINE | ID: mdl-15829251

ABSTRACT

Kynurenine 3-mono-oxygenase (KMO, kynurenine hydroxylase) inhibitors increase brain kynurenic acid (KYNA) synthesis and cause pharmacological actions possibly mediated by a reduced activity of excitatory synapses. We used in vivo microdialysis and passive avoidance to study the effects of local KYNA or systemic KMO inhibitor administration on glutamate (GLU) neurotransmission. Local application of KYNA (30-100 nM) through reverse microdialysis reduced GLU content in caudate and cortical dialysates by 75 and 55%, respectively. No changes were found in the hippocampus. Systemic administration of Ro 61-8048 (4-40 mg/kg) increased KYNA levels in dialysates obtained from the cortex (from 10.3 +/- 1.9 to 45.5 +/- 15 nM), caudate (from 2.4 +/- 0.8 to 9.5 +/- 0.9 nM) and hippocampus (from 7.7 +/- 1.7 to 19.2 +/- 3.5 nM). It also caused a parallel robust decrease in GLU levels in the dialysates collected from the caudate (from 2.2 +/- 0.5 to 0.63 +/- 0.05 microM) but not in those collected from the parietal cortex or the hippocampus. In a passive avoidance paradigm, the administration of the NMDA receptor antagonist MK-801 (0.1 mg/kg) reduced, while Ro 61-8048 (4-80 mg/kg) did not change the latency time of entering into the dark compartment on the recall trial. Our data show that KMO inhibitors increase brain KYNA synthesis and selectively reduce GLU extracellular concentration in the basal ganglia.


Subject(s)
Basal Ganglia/drug effects , Brain Chemistry/drug effects , Extracellular Space/drug effects , Glutamic Acid/metabolism , Mixed Function Oxygenases/antagonists & inhibitors , Sulfonamides/pharmacology , Thiazoles/pharmacology , Animals , Avoidance Learning/drug effects , Basal Ganglia/metabolism , Behavior, Animal/drug effects , Calcium Channel Blockers/pharmacology , Chromatography, High Pressure Liquid/methods , Dose-Response Relationship, Drug , Drug Interactions , Extracellular Space/metabolism , Kynurenic Acid/metabolism , Kynurenic Acid/pharmacology , Kynurenine 3-Monooxygenase , Male , Microdialysis/methods , Potassium Chloride/pharmacology , Rats , Rats, Wistar , Statistics, Nonparametric , Time Factors , omega-Conotoxin GVIA/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...